FdaApplication
BLA 761347
Identifiers
- fda_app_no: BLA761347
Properties
| Property | Value |
|---|---|
| applicant_name | Genentech, Inc. |
| application_type | BLA |
| approval_date | 2024-09-12 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TECENTRIQ HYBREZA | ATEZOLIZUMAB AND HYALURONIDASE-TQJS | 125MG | Injection |
1 product